CLX vs MGNX · P/E 15, rev $7.10B vs rev $39.6M
The Clorox Company (CLX) versus MacroGenics Inc (MGNX) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. MGNX currently screens at market cap $246.6M.
Not investment advice. Open the CLX and MGNX stock pages for the full models.
Not investment advice.